Home / Publications / China Insight - Lifesciences

China Insight - Lifesciences

New Blacklist System in the Field of Pharmaceutical Security


Various blacklist systems are being implemented in a number of areas of Chinese administration, and from 1 October 2012 there will be a blacklist system in place for pharmaceutical security. Pharmaceutical companies are advised to pay close attention to this.

According to the trial version of the Provisions on the Administration of a Drug Safety Blacklist (“Blacklist Provisions”) published by the State Food and Drug Administration (“SFDA”) on 13 August 2012, if any of the following events occur, the entities and those individuals in the pharmaceutical industry who are directly responsible will be added to the blacklist by the SFDA and to the counterpart list at provincial level.

Please access the Newsletter below to read more.

China Insight - Lifesciences
Read more


Nicolas Zhu
Nicolas Zhu